Suzhou Medsys Tech Co Ltd Market Cap ($881.73 Million)

$881.73 Million USD  · CN¥6.03 Billion CNY  · Rank #9125

Market Cap & Net Worth: Suzhou Medsys Tech Co Ltd (603990)

Suzhou Medsys Tech Co Ltd market cap. Suzhou Medsys Tech Co Ltd (SHG:603990) has a market capitalization of $881.73 Million (CN¥6.03 Billion) as of November 4, 2026. Listed on the SHG stock exchange, this China-based company holds position #9125 globally and #2191 in its home market, demonstrating a -3.52% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Suzhou Medsys Tech Co Ltd's stock price CN¥19.74 by its total outstanding shares 305245431 (305.25 Million). Also see 603990 cash flow conversion for how efficiently the company converts equity into cash flow.

Suzhou Medsys Tech Co Ltd Market Cap History (2016–2026)

Suzhou Medsys Tech Co Ltd market cap history from 2016 to 2026. Data shows change from $781.66 Million to $881.73 Million (-34.05% CAGR). Check Suzhou Medsys Tech Co Ltd (603990) stock price for real-time trading data and today's change.

Suzhou Medsys Tech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Suzhou Medsys Tech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 603990 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

2.26x

Suzhou Medsys Tech Co Ltd's market cap is 2.26 times its annual revenue

Industry average: 1.96x Higher than industry average

Latest Price to Earnings (P/E) Ratio

17.30x

Suzhou Medsys Tech Co Ltd's market cap is 17.30 times its annual earnings

Industry average: 273.51x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $781.66 Million $240.64 Million $45.21 Million 3.25x 17.29x
2017 $511.65 Million $268.68 Million $51.11 Million 1.90x 10.01x
2018 $470.88 Million $284.28 Million $55.48 Million 1.66x 8.49x
2019 $701.37 Million $333.12 Million $46.89 Million 2.11x 14.96x
2020 $846.98 Million $308.08 Million $35.44 Million 2.75x 23.90x
2021 $588.86 Million $353.85 Million $41.95 Million 1.66x 14.04x
2022 $655.23 Million $305.51 Million $33.56 Million 2.14x 19.52x
2023 $577.10 Million $618.14 Million -$269.42 Million 0.93x N/A
2024 $459.18 Million $464.07 Million -$279.47 Million 0.99x N/A
2025 $677.60 Million $299.60 Million $39.16 Million 2.26x 17.30x

Competitor Companies of 603990 by Market Capitalization

Companies near Suzhou Medsys Tech Co Ltd in the global market cap rankings as of November 4, 2026. Also see Suzhou Medsys Tech Co Ltd total assets for a full breakdown of the balance sheet.

Key companies related to Suzhou Medsys Tech Co Ltd by market ranking:

  • Veeva Systems Inc Class A (NYSE:VEEV): Ranked #717 globally with a market cap of $37.44 Billion USD.
  • Pro Medicus Ltd (AU:PME): Ranked #1658 globally with a market cap of $14.29 Billion USD ( AU$20.19 Billion AUD).
  • Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2014 globally with a market cap of $11.06 Billion USD.
  • BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#717 Veeva Systems Inc Class A NYSE:VEEV $37.44 Billion $307.00
#1658 Pro Medicus Ltd AU:PME $14.29 Billion AU$193.27
#2014 Tempus AI, Inc. Class A Common Stock NASDAQ:TEM $11.06 Billion $78.48
#2073 BrightSpring Health Services, Inc. Common Stock NASDAQ:BTSG $10.63 Billion $66.26

Market Capitalization of Suzhou Medsys Tech Co Ltd (2016–2026)

Market capitalization of Suzhou Medsys Tech Co Ltd from 2016 to today. Between 2016 and today, Suzhou Medsys Tech Co Ltd's market cap moved from $781.66 Million to $ 881.73 Million, with a yearly change of -34.05%.

Year Market Cap Change (%)
2026 CN¥881.73 Million +30.13%
2025 CN¥677.60 Million +47.57%
2024 CN¥459.18 Million -20.43%
2023 CN¥577.10 Million -11.92%
2022 CN¥655.23 Million +11.27%
2021 CN¥588.86 Million -30.48%
2020 CN¥846.98 Million +20.76%
2019 CN¥701.37 Million +48.95%
2018 CN¥470.88 Million -7.97%
2017 CN¥511.65 Million -34.54%
2016 CN¥781.66 Million --

End of Day Market Cap According to Different Sources

On Nov 3rd, 2026 the market cap of Suzhou Medsys Tech Co Ltd was reported to be:

Source Market Cap
Yahoo Finance $881.73 Million USD
MoneyControl $881.73 Million USD
MarketWatch $881.73 Million USD
marketcap.company $881.73 Million USD
Reuters $881.73 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Suzhou Medsys Tech Co Ltd

SHG:603990 China Health Information Services
Market Cap
$881.73 Million
CN¥6.03 Billion CNY
Market Cap Rank
#9125 Global
#2191 in China
Share Price
CN¥19.74
Change (1 day)
+4.61%
52-Week Range
CN¥13.81 - CN¥24.73
All Time High
CN¥4534.27
About

Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive… Read more